Latest News & Features
Americas
Law firm Mayer Brown has hired Mark Mansour as partner in its Washington, DC office. 2 June 2015
article
The English Court of Appeal has said pharmaceutical company Warner-Lambert has a viable argument that Actavis indirectly infringed a second medical use patent covering Warner’s drug Lyrica. 1 June 2015
Americas
A US appeals court has ruled that Actavis’s attempt to force Alzheimer’s patients to switch from one medication to another before generic companies entered the market was anti-competitive. 1 June 2015
Americas
Israel-based pharmaceutical company Teva will have to fork out $1.2 billion after a long-running dispute with the US Federal Trade Commission over a controversial ‘pay-for-delay’ case was settled. 29 May 2015
Americas
Law firm Norton Rose Fulbright has hired Andres Liivak to its New York office. 28 May 2015
Americas
Acorda Therapeutics, the first company to be targeted through an inter partes review filed by US hedge fund manager Kyle Bass, has asked the US Patent and Trademark Office to reject the petition. 28 May 2015
Asia-Pacific
The Australian health minister has revealed a series of reforms that will aim to reduce spending on patented drugs from the pharmaceutical industry. 27 May 2015
Americas
A US appeals court has issued a mixed judgment in a patent dispute that saw Novartis file infringement claims against both Watson Pharmaceuticals and Par Pharmaceutical. 26 May 2015
Big Pharma
Teva has successfully defended two patents related to its blockbuster multiple sclerosis drug Copaxone (glatiramer acetate) at the English High Court. 22 May 2015
Americas
Gilead Sciences is facing a challenge to its attempt to obtain a patent for its hepatitis C drug Sovaldi in certain Asian, Latin American and European countries. 20 May 2015